Paper39488790
Targeting the SPC25/RIOK1/MYH9 Axis to Overcome Tumor Stemness and Platinum Resistance in Epithelial Ovarian Cancer.
Jiang X and 19 others. Adv Sci (Weinh), 2024. Cited by 14 papers, by iCite.
Cite this record
ConductScience Library. Targeting the SPC25/RIOK1/MYH9 Axis to Overcome Tumor Stemness and Platinum Resistance in Epithelial Ovarian Cancer. Papers, record 39488790. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39488790
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Targeting the SPC25/RIOK1/MYH9 Axis to Overcome Tumor Stemness and Platinum Resistance in Epithelial Ovarian Cancer.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Carcinoma, Ovarian Epithelial | Major topic |
| Drug Resistance, Neoplasm | Major topic |
| Neoplastic Stem Cells | Major topic |
| Ovarian Neoplasms | Major topic |
| Myosin Heavy Chains | Major topic |
| Humans | |
| Female | |
| Mice | |
| Cell Line, Tumor | |
| Animals | |
| Wnt Signaling Pathway | |
| Platinum | |
| Antineoplastic Agents | |
| Disease Models, Animal |
Source PubMed
Grants17
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 2020YFA0509400 | National Key Research and Development Program of China | PubMed | ||
| 2023A1515012746 | Natural Science Foundation of Guangdong Province | PubMed | ||
| 2021A1515012476 | Natural Science Foundation of Guangdong Province | PubMed | ||
| 2021A1515010333 | Natural Science Foundation of Guangdong Province | PubMed | ||
| 2023M734041 | China Postdoctoral Science Foundation | PubMed | ||
| BX20230441 | China Postdoctoral Innovation Talent Support Program | PubMed | ||
| 2023A1515110871 | Basic and Applied Basic Research Foundation of Guangdong Province | PubMed | ||
| A2303050 | Shenzhen Medical Research Funds | PubMed | ||
| 81530082 | National Natural Science Foundation of China | PubMed | ||
| 82373369 | National Natural Science Foundation of China | PubMed | ||
| 82173302 | National Natural Science Foundation of China | PubMed | ||
| 82030078 | National Natural Science Foundation of China | PubMed | ||
| 82330082 | National Natural Science Foundation of China | PubMed | ||
| 82203113 | National Natural Science Foundation of China | PubMed | ||
| 82303157 | National Natural Science Foundation of China | PubMed | ||
| 82171955 | National Natural Science Foundation of China | PubMed | ||
| 81902675 | National Natural Science Foundation of China | PubMed |
Source PubMed
References63
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 17567956 | Myosin-IIA heavy-chain phosphorylation regulates the motility of MDA-MB-231 carcinoma cells. | Mol Biol Cell | 2007 | https://conductscience.org/library/papers/17567956 | PubMed |
| 2 | 24096485 | Targeting cancer stem cells to suppress acquired chemotherapy resistance. | Oncogene | 2014 | https://conductscience.org/library/papers/24096485 | PubMed |
| 3 | 23369605 | Mechanisms of chemoresistance in cancer stem cells. | Clin Transl Med | 2013 | https://conductscience.org/library/papers/23369605 | PubMed |
| 4 | 36147467 | SPC25 promotes proliferation and stemness of hepatocellular carcinoma cells via the DNA-PK/AKT/Notch1 signaling pathway. | Int J Biol Sci | 2022 | https://conductscience.org/library/papers/36147467 | PubMed |
| 5 | 28323021 | The challenge of targeting cancer stem cells to halt metastasis. | Semin Cancer Biol | 2017 | https://conductscience.org/library/papers/28323021 | PubMed |
| 6 | 22204725 | A phase 3 trial of bevacizumab in ovarian cancer. | N Engl J Med | 2011 | https://conductscience.org/library/papers/22204725 | PubMed |
| 7 | 38527625 | Bridging the gap between testing and clinics exploring alternative pre-clinical models in melanoma research. | Adv Drug Deliv Rev | 2024 | https://conductscience.org/library/papers/38527625 | PubMed |
| 8 | 35205721 | Dissecting Tumor Growth: The Role of Cancer Stem Cells in Drug Resistance and Recurrence. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/35205721 | PubMed |
| 9 | 32296030 | Targeting cancer stem cell pathways for cancer therapy. | Signal Transduct Target Ther | 2020 | https://conductscience.org/library/papers/32296030 | PubMed |
| 10 | 31245788 | Metabolic signatures of cancer cells and stem cells. | Nat Metab | 2019 | https://conductscience.org/library/papers/31245788 | PubMed |
| 11 | 29432994 | SPC25 upregulation increases cancer stem cell properties in non-small cell lung adenocarcinoma cells and independently predicts poor survival. | Biomed Pharmacother | 2018 | https://conductscience.org/library/papers/29432994 | PubMed |
| 12 | 38572751 | Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. | CA Cancer J Clin | 2024 | https://conductscience.org/library/papers/38572751 | PubMed |
| 13 | 27322403 | The GeneCards Suite: From Gene Data Mining to Disease Genome Sequence Analyses. | Curr Protoc Bioinformatics | 2016 | https://conductscience.org/library/papers/27322403 | PubMed |
| 14 | 33589595 | Targeting cancer stem cells for reversing therapy resistance: mechanism, signaling, and prospective agents. | Signal Transduct Target Ther | 2021 | https://conductscience.org/library/papers/33589595 | PubMed |
| 15 | 32791150 | Using mRNAsi to identify prognostic-related genes in endometrial carcinoma based on WGCNA. | Life Sci | 2020 | https://conductscience.org/library/papers/32791150 | PubMed |
| 16 | 30862442 | Interactions between cancer stem cells, immune system and some environmental components: Friends or foes? | Immunol Lett | 2019 | https://conductscience.org/library/papers/30862442 | PubMed |
| 17 | 25481791 | Olaparib combined with chemotherapy for recurrent platinum-sensitive ovarian cancer: a randomised phase 2 trial. | Lancet Oncol | 2015 | https://conductscience.org/library/papers/25481791 | PubMed |
| 18 | 27898521 | Pathogenesis and heterogeneity of ovarian cancer. | Curr Opin Obstet Gynecol | 2017 | https://conductscience.org/library/papers/27898521 | PubMed |
| 19 | 15865432 | Regulation of myosin-IIA assembly and Mts1 binding by heavy chain phosphorylation. | Biochemistry | 2005 | https://conductscience.org/library/papers/15865432 | PubMed |
| 20 | 37059592 | Cellular senescence-related gene signature as a valuable predictor of prognosis in hepatocellular carcinoma. | Aging (Albany NY) | 2023 | https://conductscience.org/library/papers/37059592 | PubMed |
Cited by11
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 14 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42948403 | Discovery of a small molecule RIOK1 inhibitor CINS-1 against colorectal cancer via disrupting ribosomal biosynthesis. | Acta Pharm Sin B | 2026 | https://conductscience.org/library/papers/42948403 | PubMed |
| 42220495 | The enigmatic role of tumor dormancy cells in gynecologic cancers. | Front Immunol | 2026 | https://conductscience.org/library/papers/42220495 | PubMed |
| 42212330 | Biomembrane-coated Nanoparticles Targeting circHIF1α Suppress Ovarian Cancer Metastasis and Cisplatin Resistance by Mediating System Xc⁻ Inactivation via SLC7A11/SLC3A2 to Induce Ferroptosis in Cancer Stem Cells. | Int J Biol Sci | 2026 | https://conductscience.org/library/papers/42212330 | PubMed |
| 41940421 | Targeting KIF23 inhibits cell proliferation and primary chemoresistance in cervical cancer by inactivating the MYH9/MCM2/PCNA pathway. | Clin Transl Med | 2026 | https://conductscience.org/library/papers/41940421 | PubMed |
| 41801295 | A plant alkaloid lycorine inhibits non-small cell lung cancer cell proliferation, metastasis, glycolysis and promotes ferroptosis through the ZNF143/SPC25 axis. | J Nat Med | 2026 | https://conductscience.org/library/papers/41801295 | PubMed |
| 41673219 | BUB1 promotes cell stem-like properties and serves as a diagnostic biomarker for lung cancer. | Sci Rep | 2026 | https://conductscience.org/library/papers/41673219 | PubMed |
| 41376855 | Platinum-resistant ovarian cancer: From mechanisms to treatment strategies. | Genes Dis | 2026 | https://conductscience.org/library/papers/41376855 | PubMed |
| 41375045 | Integrating Functional Genomic Screens and Multi-Omics Data to Construct a Prognostic Model for Lung Adenocarcinoma and Validating SPC25. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/41375045 | PubMed |
| 41345704 | Lactylation-driven KRT19 promotes non-small cell lung cancer progression by suppressing cellular senescence. | J Exp Clin Cancer Res | 2025 | https://conductscience.org/library/papers/41345704 | PubMed |
| 40400636 | The multifaceted functions of SPC25 in cancer: from molecular pathways to targeted therapy. | Front Med (Lausanne) | 2025 | https://conductscience.org/library/papers/40400636 | PubMed |
| 39488790 | Targeting the SPC25/RIOK1/MYH9 Axis to Overcome Tumor Stemness and Platinum Resistance in Epithelial Ovarian Cancer. | Adv Sci (Weinh) | 2024 | https://conductscience.org/library/papers/39488790 | PubMed |
Genes5
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CTNNB1 | 1499 | PubTator's text mining | https://conductscience.org/library/genes/1499 | NCBI Gene |
| MYH9 | 4627 | PubTator's text mining | https://conductscience.org/library/genes/4627 | NCBI Gene |
| RIOK1 | 83732 | PubTator's text mining | https://conductscience.org/library/genes/83732 | NCBI Gene |
| SERPINH1 | 871 | PubTator's text mining | https://conductscience.org/library/genes/871 | NCBI Gene |
| SPC25 | 57405 | PubTator's text mining | https://conductscience.org/library/genes/57405 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39488790
GET https://conductscience.org/api/papers/v1/39488790/references?page=2